Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 34.02 Billion | USD 59.97 Billion | 6.50% | 2023 |
The global blood plasma market size accrued earnings worth approximately USD 34.02 Billion in 2023 and is predicted to gain revenue of about USD 59.97 Billion by 2032, is set to record a CAGR of nearly 6.50% over the period from 2024 to 2032. The report offers valuation and analysis of Blood Plasma market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, sales estimates, avenues, current & emerging trends, and industry-validated market data.
Blood plasma is light-yellowish in color or is straw colored and it acts as liquid base for the blood. Apparently, platelets, red blood corpuscles, and leukocytes make up blood plasma. For the record, blood plasma comprise of nearly 91% to 92% of water and about 9% to 8% of solids. Apparently, coagulants present in blood plasma help in clotting of blood. Electrolytes such as sodium, chloride, calcium, and potassium in blood plasma assist in maintaining the blood pH proportion.
Furthermore, plasma proteins of blood plasma assist in retaining the colloidal osmotic pressure at nearly 25 mmHg. In addition to this, immunoglobulin present in blood plasma helps in combating various kinds of infections. Precisely, blood plasma is a composite of over seven-hundred proteins and enables proficient body functioning.
Surge in the occurrence of life-threatening disorders like hemophilia is anticipated to create lucrative growth avenues for the market over the projected timespan. Additionally, rise in the acceptance of blood plasma derived products along with a prominent surge in the aging populace prone to liver disorders will culminate in huge demand for blood plasma in the medical industry over the forecast timespan. Apart from this, a large number of benefits offered by blood plasma like coagulation of blood, defense, nutrition, maintaining of osmotic pressure, respiration, excretion, regulating of acid-base balance, and controlling body temperature has transformed into huge market demand in the current years.
Furthermore, blood plasma helps in controlling blood pressure in the human being. Rise in the health problems as a result of altering lifestyles, increase in the fund allocation to healthcare sector, and growing penetration of plasma-derived items in the healthcare industry will create lucrative growth avenues for the industry over the estimated timeline. Nonetheless, high plasma derivative treatment costs as well as post-operative risks related to plasma replacement treatment will put brakes on the industry growth over the forecast timespan.
Report Attributes | Report Details |
---|---|
Report Name | Blood Plasma Market |
Market Size in 2023 | USD 34.02 Billion |
Market Forecast in 2032 | USD 59.97 Billion |
Growth Rate | CAGR of 6.50% |
Number of Pages | 207 |
Key Companies Covered | Grifols S.A., Kedrion S.p.A., Octopharma AG, Baxter International Inc., CSL Ltd., Biotest AG, Shire, China Biologic Products, and Sanquin. |
Segments Covered | By Application, By Distribution Channel, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North American Market To Witness Mammoth Growth By 2032
The expansion of the industry in the sub-continent over the projected timeline is due to massive patient population base in the countries like the U.S. that is affected due to blood coagulation, hemostasis, and hemorrhage. Additionally, new initiatives introduced by the government for creating awareness about the significance of blood donation will proliferate the regional market expansion in the years ahead. In addition to this, occurrence of chronic disorders like heart ailments and cancer will promote the expansion of blood plasma industry in North America over the assessment timeline.
Key participants profiled in the study include
The global blood plasma market is segmented as follows:
By Application
By Distribution Channel
By Region
FrequentlyAsked Questions
Surge in the occurrence of life-threatening disorders like hemophilia is anticipated to create lucrative growth avenues for the market over the projected timespan.
According to Zion Market Research report, The global blood plasma market size accrued earnings worth approximately USD 34.02 Billion in 2023 and is predicted to gain revenue of about USD 59.97 Billion by 2032, is set to record a CAGR of nearly 6.50% over the period from 2024 to 2032.
North America is likely to make noteworthy contributions towards overall Blood Plasma Market revenue.
The key players profiled in the report include Grifols S.A., Kedrion S.p.A., Octopharma AG, Baxter International Inc., CSL Ltd., Biotest AG, Shire, China Biologic Products, and Sanquin.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed